NDSN vs STRO · P/E 31, rev $2.69B vs rev $62.0M
Nordson Corporation (NDSN) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
NDSN currently screens at market cap $16.17B and trailing P/E 31.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the NDSN and STRO stock pages for the full models.
Not investment advice.